Target intelligence / Profile preview

Maternally expressed gene 8 long non-coding RNA (MEG8)

Target
MEG8
Molecular classification
Long non-coding RNA (lncRNA), Imprinted gene, Other
01

Overview

Maternally expressed gene 8 (MEG8) is a long non-coding RNA (lncRNA) encoded within the DLK1-DIO3 imprinted locus. MEG8 does not code for a protein but regulates gene expression through multiple epigenetic and post-transcriptional mechanisms. It is known to associate with the chromatin-modifying enzyme EZH2, recruiting it to specific genomic loci to drive H3K27 methylation and transcriptional repression. MEG8 is critical for modulating epithelial-mesenchymal transition (EMT) in certain cancers, acting in concert with other lncRNAs, such as MEG3, to regulate genes involved in cell adhesion, migration, and invasion[1]. Furthermore, MEG8 functions in the immune system by acting as a competitive endogenous RNA (ceRNA), sponging microRNA-107 and regulating the expression of STAT3, a transcription factor important for the differentiation of T regulatory cells (Treg) and Th17 cells[2]. Its dysregulation has been implicated in cancer progression and in immune-related diseases characterized by T cell imbalance. MEG8 is not a direct therapeutic target (receptor, enzyme, transporter), but rather a regulatory RNA with emerging significance in epigenetics, cancer biology, and immunology[1][2].

Other names
NCRNA00024IrmRianBsrLINC00024AL132709.8lnc-MGCnon-protein coding RNA 24RNA imprinted and accumulated in nucleusImprinted RNA near Meg3/Gtl2long intergenic non-protein coding RNA 24lncRNA microRNA megacluster host gene
02

Mechanism of action

Associates with EZH2 (a component of Polycomb Repressive Complex 2) to induce H3K27 methylation and silence specific genes; Functions as a sponge for microRNA-107, thereby modulating STAT3 levels

03

Biological functions

Epigenetic regulation (chromatin modification and gene silencing)Regulation of epithelial-mesenchymal transition (EMT)Regulation of T cell differentiation (Th17/Treg balance)microRNA sponge/ceRNA activity
04

Disease associations

Cancer (especially lung and pancreatic cancer, through EMT regulation)Immune dysregulation (Th17/Treg imbalance, e.g., Henoch-Schonlein purpura)

Beyond the preview

Go deeper on Maternally expressed gene 8 long non-coding RNA (MEG8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maternally expressed gene 8 long non-coding RNA (MEG8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call